NTLA
Intellia Therapeutics Inc
12.80$
+4.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -280.8% | – | – | – | – | – | – | – | – | |
| – | +7,188.9% | +236.6% | +171.2% | +49.1% | +25.2% | +13.0% | +9.2% | +9.9% | +18.5% | +14.6% | +0.0% | |
| – | +183.1% | +413.4% | +128.2% | +11.3% | -11.5% | +31.9% | +136.2% | +94.4% | +46.7% | +15.1% | +0.0% | |
| – | -86.2% | +410.9% | +130.2% | +10.5% | -11.9% | +32.1% | +129.1% | +276.0% | – | – | – | |
| – | +869.1% | +499.1% | -127.1% | – | -750.3% | – | -139.8% | – | – | – | -720.9% | |
| – | +519.2% | +141.4% | +63.7% | -37.0% | +6.9% | -47.2% | +255.8% | +357.7% | -76.0% | -58.7% | +0.0% | |
| – | +196.1% | +141.4% | +63.7% | +2,484.3% | – | -952.0% | +156.8% | – | -119.6% | – | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -610.2% | -96.3% | – | -71.9% | +90.1% | +386.4% | +400.6% | -68.7% | – | – | – | |
| – | +267.7% | +138.0% | -14.5% | -71.9% | +90.1% | +386.4% | +98.2% | -20.9% | -77.6% | +42.5% | +0.0% | |
| – | +346.7% | +199.0% | -65.7% | -516.8% | – | – | -136.4% | – | -172.0% | – | – | |
| – | – | – | -351.7% | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.